Last 12 months
Inside the activity.
3 purchase rows · 2 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 0 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 0 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 0 | 0 |
| Jun 2026 | 0 | 1 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 3 | 1 |
| Sep 2026 | 0 | 0 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| May 30, 2003 Filed Jun 2, 2003 18:02 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 79 | $31.02 Strike: $0.00 | $2,450.58 |
DisclosureSEC source: 0000078003-03-000068 · kat347.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,261 Underlying: Common Stock · 79 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:02 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $31.02 Strike: $0.00 | $1,582.02 |
DisclosureSEC source: 0000078003-03-000069 · kin348.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,303 Underlying: Common Stock · 51 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:07 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 154 | $31.02 Strike: $0.00 | $4,777.08 |
DisclosureSEC source: 0000078003-03-000070 · mck349.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,493 Underlying: Common Stock · 154 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:07 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 215 | $31.02 Strike: $0.00 | $6,669.30 |
DisclosureSEC source: 0000078003-03-000071 · mit350.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,826 Underlying: Common Stock · 215 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:07 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 59 | $31.02 Strike: $0.00 | $1,830.18 |
DisclosureSEC source: 0000078003-03-000072 · nor351.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,188 Underlying: Common Stock · 59 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:07 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 248 | $31.02 Strike: $0.00 | $7,692.96 |
DisclosureSEC source: 0000078003-03-000073 · she352.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 31,031 Underlying: Common Stock · 248 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 30, 2003 Filed Jun 2, 2003 18:28 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units · Derivative | 9 | $31.02 Strike: $0.00 | $279.18 |
DisclosureSEC source: 0000078003-03-000074 · primary_doc.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,250 Underlying: Common Stock · 9 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 21, 2003 Filed May 23, 2003 16:31 UTC |
NORTON ROBERT Wsenior vice president
|
Giftcommon stock | 1,100 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000065 · primary_doc.xml · nonDerivative · entry 1 NORTON ROBERT W · CIK 0001174457 · senior vice president 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 248,807 F1 · balance_after: In addition, the reporting person owns 43,185 shares indirectly through the Pfizer Savings Plan. Read SEC document |
| May 15, 2003 Filed May 16, 2003 17:36 UTC |
CORR PETER BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 45 | $33.53 Strike: $0.00 | $1,508.85 |
DisclosureSEC source: 0000078003-03-000056 · cor331.xml · derivative · entry 1 CORR PETER B · CIK 0001176312 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 143 Underlying: Common Stock · 45 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 16:06 UTC |
CANGIALOSI LORETTA VVice President, Controller
|
GrantPhamtom Stock Units SSP · Derivative | 75 | $33.53 Strike: $0.00 | $2,514.75 |
DisclosureSEC source: 0000078003-03-000055 · can340.xml · derivative · entry 1 CANGIALOSI LORETTA V · CIK 0001174449 · Vice President, Controller 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,510 Underlying: Common Stock · 75 shares Expires 1988-08-08 F1 · derivative.exercise_price: These units converto to common stock on a one-for-one basis. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 17:39 UTC |
KATEN KAREN LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 169 | $33.53 Strike: $0.00 | $5,666.57 |
DisclosureSEC source: 0000078003-03-000057 · kat333.xml · derivative · entry 1 KATEN KAREN L · CIK 0001174451 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 25,182 Underlying: Common Stock · 169 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 17:59 UTC |
MITCHELL JOHN WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 354 | $33.53 Strike: $0.00 | $11,869.62 |
DisclosureSEC source: 0000078003-03-000058 · mit336.xml · derivative · entry 1 MITCHELL JOHN W · CIK 0001174455 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 47,611 Underlying: Common Stock · 354 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:00 UTC |
NORTON ROBERT WSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 135 | $33.53 Strike: $0.00 | $4,526.55 |
DisclosureSEC source: 0000078003-03-000059 · nor337.xml · derivative · entry 1 NORTON ROBERT W · CIK 0001174457 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 24,129 Underlying: Common Stock · 135 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:03 UTC |
KINDLER JEFFREY BSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 51 | $33.53 Strike: $0.00 | $1,710.03 |
DisclosureSEC source: 0000078003-03-000060 · kin334.xml · derivative · entry 1 KINDLER JEFFREY B · CIK 0001174454 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,252 Underlying: Common Stock · 51 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:03 UTC |
MCKINNELL HENRY ADirector · Chairman and CEO
|
GrantPhantom Stock Units SSP · Derivative | 373 | $33.53 Strike: $0.00 | $12,506.69 |
DisclosureSEC source: 0000078003-03-000061 · mck335.xml · derivative · entry 1 MCKINNELL HENRY A · CIK 0001174453 · Director · Chairman and CEO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 60,339 Underlying: Common Stock · 373 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:04 UTC |
SHEDLARZ DAVID LExecutive Vice President
|
GrantPhantom Stock Units SSP · Derivative | 339 | $33.53 Strike: $0.00 | $11,366.67 |
DisclosureSEC source: 0000078003-03-000062 · she338.xml · derivative · entry 1 SHEDLARZ DAVID L · CIK 0001174459 · Executive Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 30,783 Underlying: Common Stock · 339 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 15, 2003 Filed May 16, 2003 18:43 UTC |
HARDWICK CHARLES LSenior Vice President
|
GrantPhantom Stock Units SSP · Derivative | 14 | $33.53 Strike: $0.00 | $469.42 |
DisclosureSEC source: 0000078003-03-000063 · primary_doc.xml · derivative · entry 1 HARDWICK CHARLES L · CIK 0001176311 · Senior Vice President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,241 Underlying: Common Stock · 14 shares Expires 1988-08-08 F1 · derivative.exercise_price: Each unit represents one phantom share of common stock. F2 · derivative.exercise_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. F2 · derivative.expiration_date: These units, which were acquired pursuant to the Pfizer Inc. Nonfunded Deferred Compensation and Supplemental Savings Plan, are settled in cash following the reporting person's separation from service. Read SEC document |
| May 12, 2003 Filed May 15, 2003 14:44 UTC |
STEERE WILLIAM C JRDirector
|
GiftCommon Stock | 51,800 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000051 · primary_doc.xml · nonDerivative · entry 1 STEERE WILLIAM C JR · CIK 0001033870 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,978,612 F1 · balance_after: Common Stock held indirectly, as to which beneficial ownership is disclaimed: 4,936 shares held by Spouse, 331,402 shares held by Trusts. In accordance with provisions of a Grantor Retained Annuity Trust (GRAT), since the reporting person's last report, 200,000 shares previously owned directly have been contributed to a "GRAT". Read SEC document |
| April 16, 2003 Filed May 22, 2003 18:44 UTC |
MEAD DANA GDirector
|
OtherCommon Stock | 350 | $0.00 | $0.00 |
DisclosureSEC source: 0000078003-03-000064 · mea343.xml · nonDerivative · entry 1 MEAD DANA G · CIK 0001174482 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,350 F1 · kind: Received, in connection with the acquisition of Pharmacia Corporation by Pfizer Inc. (the Aquisition), in exchange for 250 shares of Pharmacia Common Stock. On the effective date of the Acquisition, April 16, 2003, each share of Pharmacia common stock was exchanged for 1.4 shares of Pfizer common stock. F1 · price: Received, in connection with the acquisition of Pharmacia Corporation by Pfizer Inc. (the Aquisition), in exchange for 250 shares of Pharmacia Common Stock. On the effective date of the Acquisition, April 16, 2003, each share of Pharmacia common stock was exchanged for 1.4 shares of Pfizer common stock. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.